Covadonga M. Díaz‐Caneja

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Marta Di Forti, Diego Quattrone, Tom P. Freeman et al. · The Lancet Psychiatry · 2019 · 807 citations · Full text

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group

Sinéad Kelly, Neda Jahanshad, Andrew Zalesky et al. · Molecular Psychiatry · 2017 · 706 citations · Full text

Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

Joaquim Raduà, Eduard Vieta, Russell T. Shinohara et al. · NeuroImage · 2020 · 256 citations · Full text

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

René S. Kahn, Inge Winter van Rossum, Stefan Leucht et al. · The Lancet Psychiatry · 2018 · 190 citations

First-episode Schizophrenia, Psychiatry, Psychotic Disorder +11

Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

Marco Solmi, Andrés Estradé, Trevor Thompson et al. · Journal of Affective Disorders · 2021 · 79 citations · Full text

Adolescent Behavioral Health, Mental Health, Covid-19 Epidemiology +16